ClinicalTrials.gg

Harpoon Therapeutics, Inc. clinical trials

Acquired by Merck & Co., Inc, Mar 11, 2024 · source ↗

The registry lists 4 studies whose lead sponsor is Harpoon Therapeutics, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 24, 2026.

Before and after it joined Merck & Co., Inc

First submitted before Harpoon Therapeutics, Inc. became part of Merck & Co., Inc
4
First submitted after Harpoon Therapeutics, Inc. became part of Merck & Co., Inc
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Harpoon Therapeutics, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Harpoon Therapeutics, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 4 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Under way, not recruiting250%
  • Completed125%
  • Stopped early125%

Phase

  • Phase 14
  • Phase 22

Where

  • United States4
  • United Kingdom1
  • Spain1
  • France1

Over the years

  1. 18
  2. 19
  3. 220
  4. 21
  5. 22
  6. 23
  7. 24
  8. 25
  9. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)4 studies

Something wrong with this grouping? Tell us on the Merck & Co., Inc page.

Studies

Recruiting first, then most recently updated. Showing 4 of 4. All Merck & Co., Inc studies →